Fang Wu

2.8k total citations
82 papers, 2.2k citations indexed

About

Fang Wu is a scholar working on Pharmaceutical Science, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Fang Wu has authored 82 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pharmaceutical Science, 15 papers in Molecular Biology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Fang Wu's work include Drug Solubulity and Delivery Systems (21 papers), Analytical Chemistry and Chromatography (8 papers) and Pharmaceutical studies and practices (8 papers). Fang Wu is often cited by papers focused on Drug Solubulity and Delivery Systems (21 papers), Analytical Chemistry and Chromatography (8 papers) and Pharmaceutical studies and practices (8 papers). Fang Wu collaborates with scholars based in United States, China and Canada. Fang Wu's co-authors include Hong Ding, Paras N. Prasad, Wing‐Cheung Law, Mark T. Swihart, Juming Yao, Sha Liu, Guanying Chen, Tymish Y. Ohulchanskyy, Hans Ågren and Xinghua Fan and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Analytical Chemistry.

In The Last Decade

Fang Wu

77 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Wu United States 23 788 665 405 294 182 82 2.2k
Zhiqiang Shen China 31 678 0.9× 814 1.2× 674 1.7× 413 1.4× 159 0.9× 116 3.1k
Xiaoqing Wang China 30 833 1.1× 454 0.7× 490 1.2× 572 1.9× 378 2.1× 219 3.4k
Lingyun Jia China 24 273 0.3× 545 0.8× 672 1.7× 351 1.2× 164 0.9× 127 2.1k
Lea Ann Dailey United Kingdom 28 548 0.7× 565 0.8× 622 1.5× 456 1.6× 193 1.1× 95 2.5k
Lingyan Liu China 31 650 0.8× 629 0.9× 1.1k 2.7× 255 0.9× 125 0.7× 197 3.5k
Michael Jay United States 31 723 0.9× 432 0.6× 792 2.0× 562 1.9× 75 0.4× 152 3.5k
Stęphan T. Stern United States 28 1.2k 1.5× 1.0k 1.5× 1.0k 2.5× 945 3.2× 60 0.3× 67 3.7k
Rashi Mathur India 20 325 0.4× 263 0.4× 246 0.6× 326 1.1× 67 0.4× 56 1.3k
Xiaodong Ye China 31 876 1.1× 1.1k 1.6× 829 2.0× 961 3.3× 242 1.3× 130 4.1k

Countries citing papers authored by Fang Wu

Since Specialization
Citations

This map shows the geographic impact of Fang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Wu more than expected).

Fields of papers citing papers by Fang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Wu. The network helps show where Fang Wu may publish in the future.

Co-authorship network of co-authors of Fang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Wu. A scholar is included among the top collaborators of Fang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Wu. Fang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Fang, et al.. (2025). Gestational zearalenone causes fetal intrauterine growth restriction partially through deriving ROS-Drp1 mediated placental PANoptosis. Ecotoxicology and Environmental Safety. 302. 118636–118636. 1 indexed citations
2.
Cheng, Yi‐Hsien, Muhammad Aqeel Ashraf, Tycho Heimbach, et al.. (2025). Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling and its Regulatory Utility to Support Oral Drug Product Development and Harmonization. Pharmaceutical Research. 42(5). 819–833. 4 indexed citations
3.
Wu, Fang, et al.. (2024). Hyaluronan-modified nanoceria for dry eye disease treatment. Journal of Colloid and Interface Science. 683(Pt 2). 215–225. 2 indexed citations
4.
Rege, Bhagwant, Andre Raw, Jingyue Yang, et al.. (2024). Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug Substances. Journal of Pharmaceutical Sciences. 113(9). 2708–2714. 2 indexed citations
5.
Cristofoletti, Rodrigo, et al.. (2024). Relative Performance of Volume of Distribution Prediction Methods for Lipophilic Drugs with Uncertainty in LogP Value. Pharmaceutical Research. 41(6). 1121–1138. 12 indexed citations
6.
Shoyaib, Abdullah Al, Arian Emami Riedmaier, Partha Pratim Roy, et al.. (2023). Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report. CPT Pharmacometrics & Systems Pharmacology. 12(5). 610–618. 11 indexed citations
7.
Yoon, Miyoung, Andrew Babiskin, Meng Hu, et al.. (2023). Increasing impact of quantitative methods and modeling in establishment of bioequivalence and characterization of drug delivery. CPT Pharmacometrics & Systems Pharmacology. 12(5). 552–555. 7 indexed citations
8.
Babiskin, Andrew, Fang Wu, Ming‐Liang Tan, et al.. (2023). Regulatory utility of mechanistic modeling to support alternative bioequivalence approaches: A workshop overview. CPT Pharmacometrics & Systems Pharmacology. 12(5). 619–623. 10 indexed citations
9.
Martinez, Marilyn N., Bálint Sinkó, Fang Wu, et al.. (2022). A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption. The AAPS Journal. 24(3). 60–60. 8 indexed citations
10.
Martinez, Marilyn N., Fang Wu, Bálint Sinkó, et al.. (2022). A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development. The AAPS Journal. 24(3). 61–61. 5 indexed citations
11.
12.
Wu, Fang, Rodrigo Cristofoletti, Liang Zhao, & Amin Rostami‐Hodjegan. (2021). Scientific considerations to move towards biowaiver for biopharmaceutical classification system class III drugs: How modeling and simulation can help. Biopharmaceutics & Drug Disposition. 42(4). 118–127. 17 indexed citations
13.
Wu, Fang, et al.. (2021). Determination of metabolites of phloretin in rats using UHPLC-LTQ-Orbitrap mass spectrometry. Tropical Journal of Pharmaceutical Research. 18(10). 2167–2173. 3 indexed citations
14.
Li, Jia, et al.. (2020). Application of Physiologically‐Based Pharmacokinetic Modeling to Predict Gastric pH‐Dependent Drug–Drug Interactions for Weak Base Drugs. CPT Pharmacometrics & Systems Pharmacology. 9(8). 456–465. 32 indexed citations
15.
16.
Wu, Fang, Matthew H. Slawson, & Kamisha L. Johnson‐Davis. (2017). Metabolic Patterns of Fentanyl, Meperidine, Methylphenidate, Tapentadol and Tramadol Observed in Urine, Serum or Plasma. Journal of Analytical Toxicology. 41(4). 289–299. 24 indexed citations
17.
Wu, Fang, et al.. (2016). Profiling and Identification of the Metabolites of Evodiamine in Rats using Ultra–Performance Liquid Chromatography with Linear Ion Trap Orbitrap Mass Spectrometer. Tropical Journal of Pharmaceutical Research. 15(3). 623–623. 9 indexed citations
18.
Kubwabo, Cariton, Xinghua Fan, Pat E. Rasmussen, & Fang Wu. (2012). Determination of synthetic musk compounds in indoor house dust by gas chromatography–ion trap mass spectrometry. Analytical and Bioanalytical Chemistry. 404(2). 467–477. 31 indexed citations
19.
Wu, Fang, Suraj G. Bhansali, Wing‐Cheung Law, et al.. (2012). Fluorescence Imaging of the Lymph Node Uptake of Proteins in Mice after Subcutaneous Injection: Molecular Weight Dependence. Pharmaceutical Research. 29(7). 1843–1853. 48 indexed citations
20.
Wu, Fang, Sherry A. Wuensch, Mitra Azadniv, Mo R. Ebrahimkhani, & Ian Nicholas Crispe. (2009). Galactosylated LDL Nanoparticles: A Novel Targeting Delivery System To Deliver Antigen to Macrophages and Enhance Antigen Specific T Cell Responses. Molecular Pharmaceutics. 6(5). 1506–1517. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiqiang Shen Breakdown of academic impact, for papers by Xiaoqing Wang Breakdown of academic impact, for papers by Lingyun Jia Breakdown of academic impact, for papers by Lea Ann Dailey Breakdown of academic impact, for papers by Lingyan Liu Breakdown of academic impact, for papers by Michael Jay Breakdown of academic impact, for papers by Stęphan T. Stern Breakdown of academic impact, for papers by Rashi Mathur Breakdown of academic impact, for papers by Xiaodong Ye
Rankless by CCL
2026